For uterine sarcomas, elevated GDF-15 may aid in discriminating aggressive sarcomas from benign leiomyomas [19], whereas for endometrial cancer increased GDF-15 expression has been reported to predict lymph node metastases and poor survival [20]. This evidence concerns the gene GDF15 and leiomyoma.